The Food and Drug Administration’s ability to protect the public from unsafe drugs and medical devices has radically deteriorated, expert witnesses told a congressional committee on Tuesday, January 29. “Without urgent action,” Gail Cassell, an Eli Lilly vice president and head of an internal FDA scientific advisory board, testified, “injury and death are certain.” continues…
No Comments »
From Medical Economics magazine, more on drugs ...
The Supreme Court has declined to consider whether dying patients have a right to be treated with experimental drugs that haven’t yet been approved by the FDA. Without comment or recorded dissent, the Court let stand a US Court of Appeals ruling that said the terminally ill have no constitutional right to drugs the agency considers safe enough only for additional testing. continues…
No Comments »
From Medical Economics magazine, more on drugs ...
The Albany Times Union tell the story of Peter Pappas, a 42 year veteran drug salesman, and how he feels about the tactics his younger colleagues use to see doctors.
“It’s dirty,” he said. “This would never have taken place 30 years ago.”
Pappas goes on to reflect on how the job of a drug rep has changed since he became one in 1965.
For drug reps, doctor is out [Via Albany Times Union]
No Comments »
From Medical Economics magazine, more on drugs ...
RSS
© 2007